LIDEX Drug Patent Profile

When do Lidex patents expire, and when can generic versions of Lidex launch?

Lidex is a drug marketed by Alvogen and is included in three NDAs.

The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidex

A generic version of LIDEX was approved as fluocinonide by TARO on June 10^th, 1987.

Summary for LIDEX

US Patents:	0
Applicants:	1
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	72
Patent Applications:	4,364
DailyMed Link:	LIDEX at DailyMed

US Patents and Regulatory Information for LIDEX

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Alvogen	LIDEX-E	fluocinonide	CREAM;TOPICAL	016908-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Alvogen	LIDEX	fluocinonide	OINTMENT;TOPICAL	016909-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	No

Expired US Patents for LIDEX

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982
Alvogen	LIDEX	fluocinonide	OINTMENT;TOPICAL	016909-002	Approved Prior to Jan 1, 1982
Alvogen	LIDEX	fluocinonide	CREAM;TOPICAL	016908-002	Approved Prior to Jan 1, 1982

International Patents for LIDEX

See the table below for patents covering LIDEX around the world.

Country	Patent Number	Title	Estimated Expiration
Hong Kong	26976	IMPROVEMENTS IN OR RELATING TO VEHICLES FOR MEDICAMENTS
France	2111912
Yugoslavia	268471